These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 32770621)

  • 1. Continuous venovenous hemodialysis may be effective in digoxin removal in digoxin toxicity: A case report.
    Gokalp C; Dogan AF; Aygun G; Kurultak I; Ustundag S
    Hemodial Int; 2020 Oct; 24(4):E58-E60. PubMed ID: 32770621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of Physiologically Based Pharmacokinetic Modeling in Point-of-Care Decisions: An Example Using Digoxin Dosing in Continuous Venovenous Hemodiafiltration.
    Srinivasan M; Hirani R; Tsiu M; Kabani K; Chaturvedula A; Palasik B
    Ther Drug Monit; 2020 Feb; 42(1):1-5. PubMed ID: 31593032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional citrate anticoagulation for high volume continuous venovenous hemodialysis in surgical patients with high bleeding risk.
    Kalb R; Kram R; Morgera S; Slowinski T; Kindgen-Milles D
    Ther Apher Dial; 2013 Apr; 17(2):202-12. PubMed ID: 23551677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous Renal Replacement Therapy: Who, When, Why, and How.
    Tandukar S; Palevsky PM
    Chest; 2019 Mar; 155(3):626-638. PubMed ID: 30266628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intermittent high-flux albumin dialysis with continuous venovenous hemodialysis for acute-on-chronic liver failure and acute kidney injury.
    Niewinski G; Raszeja-Wyszomirska J; Hrenczuk M; Rozga A; Malkowski P; Rozga J
    Artif Organs; 2020 Jan; 44(1):91-99. PubMed ID: 31267563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symptomatic digoxin toxicity in a patient on haemodialysis.
    Delicata L; Gatt A; Paris JL; Bonello J
    BMJ Case Rep; 2020 Jun; 13(6):. PubMed ID: 32546555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Removal of linezolid by conventional intermittent hemodialysis, sustained low-efficiency dialysis, or continuous venovenous hemofiltration in patients with acute renal failure.
    Fiaccadori E; Maggiore U; Rotelli C; Giacosa R; Parenti E; Picetti E; Sagripanti S; Manini P; Andreoli R; Cabassi A
    Crit Care Med; 2004 Dec; 32(12):2437-42. PubMed ID: 15599148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Digoxin intoxication in a patient with end-stage renal disease: efficacy of digoxin-specific Fab antibody fragments and peritoneal dialysis.
    Caspi O; Zylber-Katz E; Gotsman O; Wolf DG; Caraco Y
    Ther Drug Monit; 1997 Oct; 19(5):510-5. PubMed ID: 9357092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Digoxin-specific antibody fragments in the treatment of digoxin toxicity.
    Chan BS; Buckley NA
    Clin Toxicol (Phila); 2014; 52(8):824-36. PubMed ID: 25089630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute digoxin overdose in a newborn with renal failure: use of digoxin immune Fab and peritoneal dialysis.
    Berkovitch M; Akilesh MR; Gerace R; Verjee Z; McGuigan M; Whyte H; Koren G
    Ther Drug Monit; 1994 Oct; 16(5):531-3. PubMed ID: 7846755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous venovenous hemodialysis.
    Strohschein BL; Caruso DM; Greene KA
    Am J Crit Care; 1994 Mar; 3(2):92-9; quiz 100-1. PubMed ID: 8167781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperkalemia complicating digoxin toxicity in a patient with renal failure.
    Papadakis MA; Wexman MP; Fraser C; Sedlacek SM
    Am J Kidney Dis; 1985 Jan; 5(1):64-6. PubMed ID: 3966471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracorporeal treatment for digoxin poisoning: systematic review and recommendations from the EXTRIP Workgroup.
    Mowry JB; Burdmann EA; Anseeuw K; Ayoub P; Ghannoum M; Hoffman RS; Lavergne V; Nolin TD; Gosselin S;
    Clin Toxicol (Phila); 2016; 54(2):103-14. PubMed ID: 26795743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluconazole Exposure in Plasma and Bile During Continuous Venovenous Hemodialysis.
    Oualha M; Tréluyer JM; Moshous D; Bougnoux ME; Starck J; Renolleau S; Gana I; Benaboud S
    Ther Drug Monit; 2019 Aug; 41(4):544-546. PubMed ID: 31259879
    [No Abstract]   [Full Text] [Related]  

  • 15. Severe theophylline poisoning treated with continuous venovenous hemodialysis in a child.
    Yaman A; Kendirli T; Ödek Ç; Azapağası E; Erkol H; Pişkin İE; Teber-Tıraş S; Yalçınkaya F
    Turk J Pediatr; 2016; 58(3):297-300. PubMed ID: 28266196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elderly patients with suspected chronic digoxin toxicity: A comparison of clinical characteristics of patients receiving and not receiving digoxin-Fab.
    Arbabian H; Lee HM; Graudins A
    Emerg Med Australas; 2018 Apr; 30(2):242-248. PubMed ID: 29316267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of digoxin therapy using pharmacokinetics in a patient undergoing continuous venovenous hemofiltration.
    Benken ST; Lizza BD; Yamout H; Ghossein C
    Am J Health Syst Pharm; 2013 Dec; 70(23):2105-9. PubMed ID: 24249760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of hyperkalemia in a patient with unrecognized digitalis toxicity.
    Van Deusen SK; Birkhahn RH; Gaeta TJ
    J Toxicol Clin Toxicol; 2003; 41(4):373-6. PubMed ID: 12870880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal replacement therapy after repair of congenital heart disease in children. A comparison of hemofiltration and peritoneal dialysis.
    Fleming F; Bohn D; Edwards H; Cox P; Geary D; McCrindle BW; Williams WG
    J Thorac Cardiovasc Surg; 1995 Feb; 109(2):322-31. PubMed ID: 7853885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of extreme hyponatremia in an anuric patient using continuous venovenous hemodialysis.
    Viktorsdottir O; Indridason OS; Palsson R
    Blood Purif; 2013; 36(3-4):274-9. PubMed ID: 24496199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.